BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19552464)

  • 1. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
    Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
    Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exo-cyclopamine--a stable and potent inhibitor of hedgehog-signaling.
    Heretsch P; Büttner A; Tzagkaroulaki L; Zahn S; Kirchner B; Giannis A
    Chem Commun (Camb); 2011 Jul; 47(26):7362-4. PubMed ID: 21589966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
    Tremblay MR; Nevalainen M; Nair SJ; Porter JR; Castro AC; Behnke ML; Yu LC; Hagel M; White K; Faia K; Grenier L; Campbell MJ; Cushing J; Woodward CN; Hoyt J; Foley MA; Read MA; Sydor JR; Tong JK; Palombella VJ; McGovern K; Adams J
    J Med Chem; 2008 Nov; 51(21):6646-9. PubMed ID: 18842035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopamine inhibition of Sonic hedgehog signal transduction is not mediated through effects on cholesterol transport.
    Incardona JP; Gaffield W; Lange Y; Cooney A; Pentchev PG; Liu S; Watson JA; Kapur RP; Roelink H
    Dev Biol; 2000 Aug; 224(2):440-52. PubMed ID: 10926779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of desmethylveramiline, a micromolar Hedgehog inhibitor.
    Guerlet G; Spangenberg T; Mann A; Faure H; Ruat M
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3608-12. PubMed ID: 21592788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective synthesis of F-ring saturated estrone-derived inhibitors of Hedgehog signaling based on cyclopamine.
    Zhang Z; Baubet V; Ventocilla C; Xiang C; Dahmane N; Winkler JD
    Org Lett; 2011 Sep; 13(18):4786-9. PubMed ID: 21842835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of cyclopamine using a biomimetic and diastereoselective approach.
    Giannis A; Heretsch P; Sarli V; Stössel A
    Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183
    [No Abstract]   [Full Text] [Related]  

  • 8. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition.
    El-Zaatari M; Grabowska AM; McKenzie AJ; Powe DG; Scotting PJ; Watson SA
    Regul Pept; 2008 Feb; 146(1-3):131-9. PubMed ID: 17996964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From teratogens to potential therapeutics: natural inhibitors of the Hedgehog signaling network come of age.
    Hovhannisyan A; Matz M; Gebhardt R
    Planta Med; 2009 Oct; 75(13):1371-80. PubMed ID: 19639534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog signaling is essential for normal wound healing.
    Le H; Kleinerman R; Lerman OZ; Brown D; Galiano R; Gurtner GC; Warren SM; Levine JP; Saadeh PB
    Wound Repair Regen; 2008; 16(6):768-73. PubMed ID: 19128247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of several dietary alkaloids as weak inhibitors of hedgehog signaling.
    Lipinski RJ; Dengler E; Kiehn M; Peterson RE; Bushman W
    Toxicol Sci; 2007 Dec; 100(2):456-63. PubMed ID: 17728282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclopamine and hedgehog signaling: chemistry, biology, medical perspectives.
    Heretsch P; Tzagkaroulaki L; Giannis A
    Angew Chem Int Ed Engl; 2010 May; 49(20):3418-27. PubMed ID: 20429080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified.
    Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S
    J Pharm Biomed Anal; 2010 Sep; 52(5):707-13. PubMed ID: 20236786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology-driven diversity: concept of focused diversity.
    Kiselyov AS
    Chem Biol Drug Des; 2006 Jul; 68(1):67-9. PubMed ID: 16923028
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Sonic hedgehog signaling leads to posterior digit loss in Ambystoma mexicanum: parallels to natural digit reduction in urodeles.
    Stopper GF; Wagner GP
    Dev Dyn; 2007 Jan; 236(1):321-31. PubMed ID: 17117438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro.
    Chen XL; Cheng QY; She MR; Wang Q; Huang XH; Cao LQ; Fu XH; Chen JS
    Arch Med Res; 2010 Jul; 41(5):315-23. PubMed ID: 20851287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity studies of cyclopamine derivatives.
    Zhang J; Garrossian M; Gardner D; Garrossian A; Chang YT; Kim YK; Chang CW
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1359-63. PubMed ID: 18221872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
    Xu FG; Ma QY; Wang Z
    Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog signaling in the murine melanoma microenvironment.
    Geng L; Cuneo KC; Cooper MK; Wang H; Sekhar K; Fu A; Hallahan DE
    Angiogenesis; 2007; 10(4):259-67. PubMed ID: 17762973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.